The DOI matches its Crossref record.
Neuroprotection with a calpain inhibitor in a model of focal cerebral ischemia.
Open accessAbstract
Excessive elevation of intracellular calcium and uncontrolled activation of calcium-sensitive events are believed to play a central role in ischemic neuronal damage. Calcium-activated proteolysis by calpain is a candidate to participate in this form of pathology because it is activated under ischemic conditions and its activation results in the degradation of crucial cytoskeletal and regulatory proteins. The present studies examined the effects of a cell-penetrating inhibitor of calpain on the pathological outcome after transient focal ischemia in the brain. Twenty-five male Sprague-Dawley rats were divided into four groups: a saline-treated group, a vehicle-treated group, and two calpain inhibitor-treated groups (Cbz-Val-Phe-H; 30-mg/kg and 60-mg/kg cumulative doses). Ischemia was induced by occluding the left middle cerebral artery and both common carotid arteries for 3 hours followed by reperfusion. Animals were killed 72 hours after surgery, and quantitative measurements of infarction volumes were performed using histological techniques. Eight additional rats were killed 30 minutes after ischemia and examined for the extent of proteolysis using immunoblot techniques. A final group of 12 animals was decapitated after injection of vehicle or calpain inhibitor, and the proteolytic response was measured after 60 minutes of total ischemia. Rats treated with Cbz-Val-Phe-H exhibited significantly smaller volumes of cerebral infarction than saline-treated or vehicle-treated control animals. Intravenous injections of cumulative doses of 30 mg/kg or 60 mg/kg of Cbz-Val-Phe-H were effective in reducing infarction, edema, and calcium-activated proteolysis. The proteolytic response to postdecapitation ischemia was also reduced by the calpain inhibitor. These results demonstrate the neuroprotective effect of a cell-penetrating calpain inhibitor when administered systemically. The findings suggest that targeting intracellular, calcium-activated mechanisms, such as proteolysis, represents a viable therapeutic strategy for limiting neurological damage after ischemia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Glutamate receptors, neurotoxicity and neurodegeneration
Lau, A., & Tymianski, M. (2010) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-010-0809-1 · Cited by 1,185
Fricker, M., Tolkovsky, A. M., Borutaite, V., Coleman, M., & Brown, G. C. (2018) · Physiological Reviews · doi:10.1152/physrev.00011.2017 · Cited by 1,108
Mattson, M. P. (2007) · Aging Cell · doi:10.1111/j.1474-9726.2007.00275.x · Cited by 751
Chong, Z. Z., Li, F., & Maiese, K. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.02.004 · Cited by 536
All roads lead to disconnection? – Traumatic axonal injury revisited
Büki, A., & Povlishock, J. T. (2006) · Acta Neurochirurgica · doi:10.1007/s00701-005-0674-4 · Cited by 503
Calpain-Mediated Signaling Mechanisms in Neuronal Injury and Neurodegeneration
Vosler, P. S., Brennan, C. S., & Chen, J. (2008) · Molecular Neurobiology · doi:10.1007/s12035-008-8036-x · Cited by 382
Yamashima, T. (2000) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00006-x · Cited by 349
Novel Pharmacologic Strategies in the Treatment of Experimental Traumatic Brain Injury: 1998
McINTOSH, T. K., JUHLER, M., & WIELOCH, T. (1998) · Journal of Neurotrauma · doi:10.1089/neu.1998.15.731 · Cited by 298
Wang, K. K., Nath, R., Posner, A., Raser, K. J., Buroker-Kilgore, M., Hajimohammadreza, I., Probert A, W., Marcoux, F. W., Ye, Q., Takano, E., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.13.6687 · Cited by 275
Self-citationCalpain inhibition: an overview of its therapeutic potential
Wang, K. K. W., & Po-Wai, Y. (1994) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(94)90090-6 · Cited by 274
Cellular and Molecular Pathways of Ischemic Neuronal Death
Won, S.-J., Kim, D.-Y., & Gwag, B.-J. (2002) · BMB Reports · doi:10.5483/bmbrep.2002.35.1.067 · Cited by 260
Dourdin, N., Bhatt, A. K., Dutt, P., Greer, P. A., Arthur, J. S. C., Elce, J. S., & Huttenlocher, A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m108893200 · Cited by 258
Tuo, Q.-Z., Liuyang, Z.-Y., Lei, P., Yan, X., Shentu, Y.-P., Liang, J.-W., Zhou, H., Pei, L., Xiong, Y., Hou, T.-Y., et al. (2018) · Cell Death & Disease · doi:10.1038/s41419-018-0929-7 · Cited by 44
Metadata
- Authors
- Hong, S. C., Goto, Y., Lanzino, G., Soleau, S., Kassell, N. F., & Lee, K. S.
- Venue
- Stroke
- Published
- 1994-03
- Volume
- 25
- Issue
- 3
- Pages
- 663-669
- ISSN
- 0039-2499 (ISSN-L)
- 1524-4628
- OpenAlex
- W1992372295
- Cited by
- 180
- References
- 0
- FWCI
- 6.16
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.